We believe that further cell transfection and transcriptome analysis are warranted to identify the signal pathway of renal pathological changes caused by IFIT1 expression and to provide evidence for the establishment of novel therapeutic strategy against SLE. This evidence concerns the gene IFIT1 and systemic lupus erythematosus.